The molecular basis of osteoclast differentiation and activation - PubMed (original) (raw)
Review
. 2001:232:235-47; discussion 247-50.
doi: 10.1002/0470846658.ch16.
Affiliations
- PMID: 11277084
- DOI: 10.1002/0470846658.ch16
Review
The molecular basis of osteoclast differentiation and activation
T Suda et al. Novartis Found Symp. 2001.
Abstract
Osteoclasts develop from haemopoietic cells of the monocyte-macrophage lineage. Osteoblasts or stromal cells are essentially involved in osteoclastogenesis through cell-cell interaction with osteoclast progenitor cells. Recent findings indicate that osteoblasts/stromal cells express osteoclast differentiation factor (ODF, also called RANKL, TRANCE and OPGL) as a membrane-associated factor in response to several osteotropic factors to support osteoclast differentiation. ODF is a new member of the tumour necrosis factor (TNF) ligand family. Osteoclast precursors, which express RANK, a TNF receptor family member, recognize ODF through cell-cell interactions with osteoblasts/stromal cells, and differentiate into osteoclasts in the presence of macrophage colony-stimulating factor (M-CSF). Osteoclastogenesis inhibitory factor (OCIF, also called OPG), is a secreted TNF receptor, which acts as a decoy receptor for ODF. ODF is responsible for inducing not only differentiation, but also activation of osteoclasts. Interleukin 1 alpha (IL-1 alpha) can be substituted for ODF in inducing the activation of osteoclasts. Recently, it was shown that mouse TNF alpha stimulated the differentiation of M-CSF-dependent mouse bone marrow macrophages into osteoclasts in the presence of M-CSF without any help of osteoblasts/stromal cells. Osteoclast formation induced by TNF alpha was inhibited by antibodies against TNF type 1 receptor (TNFR1) or TNFR2, but not by OCIF. Osteoclasts induced by TNF alpha formed resorption pits on dentine slices only in the presence of IL-1 alpha. These results demonstrate that TNF alpha stimulates osteoclast differentiation through a mechanism independent of the ODF-RANK interaction. TNF alpha and IL-1 alpha may play an important role in pathological bone resorption due to inflammation.
Similar articles
- Osteoblasts/stromal cells stimulate osteoclast activation through expression of osteoclast differentiation factor/RANKL but not macrophage colony-stimulating factor: receptor activator of NF-kappa B ligand.
Udagawa N, Takahashi N, Jimi E, Matsuzaki K, Tsurukai T, Itoh K, Nakagawa N, Yasuda H, Goto M, Tsuda E, Higashio K, Gillespie MT, Martin TJ, Suda T. Udagawa N, et al. Bone. 1999 Nov;25(5):517-23. doi: 10.1016/s8756-3282(99)00210-0. Bone. 1999. PMID: 10574571 - Tumor necrosis factor alpha stimulates osteoclast differentiation by a mechanism independent of the ODF/RANKL-RANK interaction.
Kobayashi K, Takahashi N, Jimi E, Udagawa N, Takami M, Kotake S, Nakagawa N, Kinosaki M, Yamaguchi K, Shima N, Yasuda H, Morinaga T, Higashio K, Martin TJ, Suda T. Kobayashi K, et al. J Exp Med. 2000 Jan 17;191(2):275-86. doi: 10.1084/jem.191.2.275. J Exp Med. 2000. PMID: 10637272 Free PMC article. - A new member of tumor necrosis factor ligand family, ODF/OPGL/TRANCE/RANKL, regulates osteoclast differentiation and function.
Takahashi N, Udagawa N, Suda T. Takahashi N, et al. Biochem Biophys Res Commun. 1999 Mar 24;256(3):449-55. doi: 10.1006/bbrc.1999.0252. Biochem Biophys Res Commun. 1999. PMID: 10080918 Review. - A novel molecular mechanism modulating osteoclast differentiation and function.
Yasuda H, Shima N, Nakagawa N, Yamaguchi K, Kinosaki M, Goto M, Mochizuki SI, Tsuda E, Morinaga T, Udagawa N, Takahashi N, Suda T, Higashio K. Yasuda H, et al. Bone. 1999 Jul;25(1):109-13. doi: 10.1016/s8756-3282(99)00121-0. Bone. 1999. PMID: 10423033 - Modulation of osteoclast differentiation and function by the new members of the tumor necrosis factor receptor and ligand families.
Suda T, Takahashi N, Udagawa N, Jimi E, Gillespie MT, Martin TJ. Suda T, et al. Endocr Rev. 1999 Jun;20(3):345-57. doi: 10.1210/edrv.20.3.0367. Endocr Rev. 1999. PMID: 10368775 Review.
Cited by
- Artemisinic acid attenuates osteoclast formation and titanium particle-induced osteolysis via inhibition of RANKL-induced ROS accumulation and MAPK and NF-κB signaling pathways.
Gao T, Yu C, Shi X, Hu Y, Chang Y, Zhang J, Wang Y, Zhai Z, Jia X, Mao Y. Gao T, et al. Front Pharmacol. 2024 May 1;15:1345380. doi: 10.3389/fphar.2024.1345380. eCollection 2024. Front Pharmacol. 2024. PMID: 38751789 Free PMC article. - Microbiota metabolites in bone: Shaping health and Confronting disease.
Han D, Wang W, Gong J, Ma Y, Li Y. Han D, et al. Heliyon. 2024 Mar 20;10(7):e28435. doi: 10.1016/j.heliyon.2024.e28435. eCollection 2024 Apr 15. Heliyon. 2024. PMID: 38560225 Free PMC article. Review. - The effect of cytokines on osteoblasts and osteoclasts in bone remodeling in osteoporosis: a review.
Xu J, Yu L, Liu F, Wan L, Deng Z. Xu J, et al. Front Immunol. 2023 Jul 5;14:1222129. doi: 10.3389/fimmu.2023.1222129. eCollection 2023. Front Immunol. 2023. PMID: 37475866 Free PMC article. Review. - The Diverse Roles of 17β-Estradiol in Non-Gonadal Tissues and Its Consequential Impact on Reproduction in Laying and Broiler Breeder Hens.
Hanlon C, Ziezold CJ, Bédécarrats GY. Hanlon C, et al. Front Physiol. 2022 Jul 1;13:942790. doi: 10.3389/fphys.2022.942790. eCollection 2022. Front Physiol. 2022. PMID: 35846017 Free PMC article. Review. - Transcriptomic Analysis Provides Insights to Reveal the bmp6 Function Related to the Development of Intermuscular Bones in Zebrafish.
Xu H, Tong G, Yan T, Dong L, Yang X, Dou D, Sun Z, Liu T, Zheng X, Yang J, Sun X, Zhou Y, Kuang Y. Xu H, et al. Front Cell Dev Biol. 2022 May 12;10:821471. doi: 10.3389/fcell.2022.821471. eCollection 2022. Front Cell Dev Biol. 2022. PMID: 35646941 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Other Literature Sources
Medical
Research Materials